European journal of gastroenterology & hepatology, 34(10), 983-992. Lippincott Williams and Wilkins European Journal of Gastroenterology & Hepatology, 34, 983-992 European journal of gastroenterology & hepatology, 34(10), 983-992. Lippincott Williams & Wilkins European Journal of Gastroenterology & Hepatology, 34, 10, pp. 983-992 European Journal of Gastroenterology & Hepatology, 34(10), 983-992. LIPPINCOTT WILLIAMS & WILKINS ten Bokkel Huinink, S, de Jong, D C, Nieboer, D, Thomassen, D, Steyerberg, E W, Dijkgraaf, M G W, Bodelier, A G L, West, R L, Römkens, T E H, Hoentjen, F, Mallant, R C, van Tuyl, B A C, Mares, W G N, Wolfhagen, F H J, Dijkstra, G, Reijnders, J G P, de Boer, N K, Tan, A C I T L, van Boeckel, P G A, Tack, G J, van Asseldonk, D P, D'Haens, G R A M, van der Woude, C J, Duijvestein, M & de Vries, A C 2022, ' Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn's disease ', European journal of gastroenterology & hepatology, vol. 34, no. 10, pp. 983-992 . https://doi.org/10.1097/MEG.0000000000002403